Showing results (691-700 of 784) with videos related to
Sort By:
Pageof 79
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.Annals of the Rheumatic Diseases|June 7, 2020
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2Robert Bm Landewé, Pedro M Machado, Féline Kroon, et al.Mutation Research|July 23, 2003
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association studySiqun L Zheng, Josyf C Mychaleckyj, Gregory A Hawkins, et al.Journal of the American Medical Directors Association|August 8, 2022
Emergency Department Communication in Persons Living With Dementia and Care Partners: A Scoping ReviewChristopher R Carpenter, Jesseca Leggett, Fernanda Bellolio, et al.Annals of the Rheumatic Diseases|July 24, 2007
Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseC H Burgoyne, S L Field, A K Brown, et al.Proceedings of the National Academy of Sciences of the United States of America|February 11, 2004
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish familiesDanielle M Friedrichsen, Janet L Stanford, Sarah D Isaacs, et al.Cancer Research|January 2, 2009
Sequence variants at 22q13 are associated with prostate cancer riskJielin Sun, Siqun Lilly Zheng, Fredrik Wiklund, et al.RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.Annals of the Rheumatic Diseases|May 21, 2013
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentRebeccah J Mathews, James I Robinson, Michele Battellino, et al.Annals of the New York Academy of Sciences|March 26, 2011
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentariumBach-Yen T Nguyen, Robin D Isaacs, Hedy Teppler, et al.Pageof 79